13F
← All fund report cards

MILLER HOWARD INVESTMENTS INC /NY

13F equity value
$3.7B
Positions
138
Top 10 concentration
25.8%
Quarters / total new picks
32 / 340
13F equity value over time
$0M$2B$5B2017201820192020202120222023202420252026

"13F equity value" = market value of this filer's US-listed long equity positions only. It excludes cash, bonds, non-US and short positions, so it understates a fund's true assets under management — often by a lot.

Not significant Verdict

13F holdings are disclosed ~45 days after quarter-end, and they never reveal when within the quarter a fund actually bought. So any 13F-based summary is structurally late and blurred — this applies to every fund, including this one.

We backtested copying it anyway. Buying this fund's new positions the day each filing went public, over 32 quarters, returned +3.4% per quarter — versus +2.7% per quarter from simply owning every 13F stock. It beat that baseline in only 53.1% of quarters (excess t = 0.01, not statistically significant). Its filings tell you what it bought — not what you should buy.

Avg 2Q excess
+0.0%
t-stat
0.01
Quarterly win rate
53%
Annualized excess
+3.0%
$1 → follow vs universe
$2.59 vs $2.09
Cumulative return: $1 invested in new picks vs universe
1.00 20180331: universe 1.04120180630: universe 0.95920180930: universe 1.00320181231: universe 0.99220190331: universe 0.97520190630: universe 1.04820190930: universe 1.12720191231: universe 0.90920200331: universe 1.09620200630: universe 1.21120200930: universe 1.48520201231: universe 1.55320210331: universe 1.56620210630: universe 1.69220210930: universe 1.51920211231: universe 1.29220220331: universe 1.38720220630: universe 1.28520220930: universe 1.38120221231: universe 1.28220230331: universe 1.35120230630: universe 1.30320230930: universe 1.47920231231: universe 1.54520240331: universe 1.58020240630: universe 1.72320240930: universe 1.70820241231: universe 1.59420250331: universe 1.73820250630: universe 1.79320250930: universe 2.01620251231: universe 2.085 20180331: follow 0.95020180630: follow 0.91120180930: follow 0.95420181231: follow 1.00320190331: follow 0.97320190630: follow 1.15620190930: follow 1.22520191231: follow 0.92220200331: follow 1.01120200630: follow 1.03720200930: follow 1.17220201231: follow 1.35920210331: follow 1.37120210630: follow 1.40320210930: follow 1.59220211231: follow 1.72720220331: follow 1.74820220630: follow 1.76020220930: follow 1.92220221231: follow 1.70220230331: follow 1.89420230630: follow 1.95520230930: follow 2.12620231231: follow 2.45120240331: follow 2.52220240630: follow 2.40720240930: follow 2.40020241231: follow 2.50620250331: follow 2.56020250630: follow 2.66320250930: follow 2.91520251231: follow 2.591 0.84 1.99 3.15 20182019202020212022202320242025 Follow Universe

Quarterly compounding, invested quarters only · entry 47 days after quarter-end (when 13F data becomes public)

Listed as facts. See the verdict above before treating this as signal.

Top 20 holdings of 138 · 2026 Q1

Ticker Value Weight QoQ
MPLX $128M
3.5%
TRIM
EPD $120M
3.3%
HOLD
ET $101M
2.8%
HOLD
JNJ $99M
2.7%
TRIM
GSK $90M
2.5%
HOLD
ABBV $87M
2.4%
HOLD
EXC $83M
2.3%
ADD
TRP $81M
2.2%
ADD
COP $81M
2.2%
ADD
STT $75M
2.1%
HOLD
CNQ $70M
1.9%
ADD
ETR $70M
1.9%
HOLD
ORI $66M
1.8%
TRIM
EWBC $65M
1.8%
HOLD
WES $65M
1.8%
ADD
ENB $63M
1.7%
ADD
WMB $63M
1.7%
TRIM
PAA $63M
1.7%
HOLD
MDT $62M
1.7%
HOLD
KMI $61M
1.7%
ADD

QoQ vs previous quarter's share count · NEW = new position · ADD/TRIM = ±2% shares · HOLD = unchanged.

Listed as facts. See the verdict above before treating this as signal.

New positions in 2026 Q1

Method & Limitations

Method: a "new position" = held this quarter, absent last quarter (options excluded; stocks with <50 prior holders excluded to filter spin-off artifacts). Entry 47 days after quarter-end — the first day the public could act on the filing. Benchmark = equal-weighted universe of all 13F-held stocks. Limitations: quarterly snapshots can't see intra-quarter trades; survivorship bias — funds that shut down are absent, which flatters the sample. Statistics, not advice.